Endocrine oncology

Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

Risk of PA in MEN1 clusters at younger ages and declines thereafter. Prior primary hyperparathyroidism, non-missense MEN1 PVs, and female sex further mark higher-risk profiles. These findings may help personalize PA follow-up-prioritizing closer imaging in early adulthood and allowing longer intervals when baseline imaging is normal and additional risk markers are absent-pending validation in larger multicenter studies.

Study context

Population
MEN1 patients, 55.8% female
Participants
240 patients
Outcome
PA development
Methodological detailsnationwide, multicenter
  • Nationwide
  • Multicenter

Main finding

As reported in the abstract

Independent factors for PA development (full cohort, Cox regression)

Pituitary adenomas (PAs) detected

112

46.6%

Observational data: associations, not effects.

Further findings

PA characteristics

Mean age at PA detection, years
36.1 ± 13.9
Diagnosed through screening
63.3%
Prolactinomas
49.1%
Microadenomas
62.5%

Independent factors in prospectively screened subgroup (n = 199)

The same factors remained significant in the screened subgroup

Original publication

Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases. J Clin Endocrinol Metab. Published 8 September 2025. doi:10.1210/clinem/dgaf497

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.